Long Grove Team

Generic Pharmaceuticals
that Elevate All

Meet the next generation of generic pharmaceuticals. Emerging specialty pharmaceutical company focused on complex generics, including injectables and topical products, Long Grove Pharmaceuticals is committed to improving customer choice while increasing access for patients.

Long Grove utilizes established manufacturers in Western Europe, North America, and Asia to ensure strict quality control.

We’re building a better tomorrow by investing in high-quality pharmaceutical options that offer our customers security when they need it most.

Meet the next generation of generic pharmaceuticals. An emerging specialty pharmaceutical company focused on complex generics, including injectables and topical products, Long Grove Pharmaceuticals is committed to improving customer choice while increasing access for patients.

Long Grove utilizes well-established manufacturers in Western Europe, North America, and Asia to ensure strict quality control.

We’re building a better tomorrow by investing in high-quality pharmaceutical options that offer our customers security when they need it most.

Innovating Smartly

Long Grove Pharmaceuticals utilizes the Abbreviated New Drug Application (ANDA) regulatory pathway for more rapid product approvals to ensure a more efficient process. Additionally, we’re simultaneously developing our own proprietary products through the 505(b)(2) regulatory pathway, bringing needed solutions to our partners.

Innovating Smartly

Long Grove Pharmaceuticals utilizes the Abbreviated New Drug Application (ANDA) regulatory pathway for more rapid product approvals to ensure a more efficient process. Additionally, we’re simultaneously developing our own proprietary products through the 505(b)(2) regulatory pathway, bringing needed solutions to our partners.

Flexible & Trusted

With competitive advantages in how we source and reformulate our products, our portfolio of generic pharmaceuticals has built-in flexibility. From changes in elements of variation, like concentration and volume, Long Grove Pharmaceuticals is uniquely positioned to address the complex needs of pharmacies in every facet of healthcare. From hospitals to oncology clinics, long-term care to dental, wholesale and retail, the Long Grove family of generic pharmaceuticals offers providers greater choice.

Flexible & Trusted

With competitive advantages in how we source and reformulate our products, our portfolio of generic pharmaceuticals has built-in flexibility. From changes in elements of variation, like concentration and volume, Long Grove Pharmaceuticals is uniquely positioned to address the complex needs of pharmacies in every facet of healthcare. From hospitals to oncology clinics, long-term care to dental, wholesale and retail, the Long Grove family of generic pharmaceuticals offers providers greater choice.

Why We’re Different

At Long Grove Pharmaceuticals, we’re cultivating new and needed solutions across the generics market by combining our skill, expertise, and commitment to quality. Here are three reasons we’re elevating the industry and its offerings…

Resilient Supply Chain

By utilizing an innovative dual pathway to regulatory approval, we are well-poised to provide long-awaited, high-barrier-to-entry products, all manufactured through a robust and diverse supply chain. This approach allows Long Grove to navigate challenging manufacturing and supply chain dynamics to bring high-demand, high-quality products to niche markets while also actively pursuing a robust pipeline of partnership and product development opportunities.

Meticulously Detail-Orientated

From dedicated equipment to experience in navigating manufacturing challenges unique to the intravenous injectables market (including difficult APIs and complicated fill finished products) we’ve solved the biggest problems first to ensure our products are as accessible to our customers and the patients they serve.

Complimentary Experience. Fierce Commitment.

Rapidly scaling complex pharmaceutical formulations is no small feat. With more than 100 years of combined experience in pharmaceuticals, our tenured and multi-functional leadership team has collectively helped to build more than a dozen successful pharmaceutical companies.

 

 

Why We’re Different

At Long Grove Pharmaceuticals, we’re cultivating new and needed solutions across the generics market by combining our skill, expertise, and commitment to quality. Here are three reasons we’re elevating the industry and its offerings…

Resilient Supply Chain

By utilizing an innovative dual pathway to regulatory approval, we are well-poised to provide long-awaited, high-barrier-to-entry products, all manufactured through a robust and diverse supply chain. This approach allows Long Grove to navigate challenging manufacturing and supply chain dynamics to bring high-demand, high-quality products to niche markets while also actively pursuing a robust pipeline of partnership and product development opportunities.

Meticulously Detail-Orientated

From dedicated equipment to experience in navigating manufacturing challenges unique to the intravenous injectables market (including difficult APIs and complicated fill finished products) we’ve solved the biggest problems first to ensure our products are as accessible to our customers and the patients they serve.

Complimentary Experience. Fierce Commitment.

Rapidly scaling complex pharmaceutical formulations is no small feat. With more than 100 years of combined experience in pharmaceuticals, our tenured and multi-functional leadership team has collectively helped to build more than a dozen successful pharmaceutical companies.

 

 

Long Grove Team

“Long Grove is a new source of generics with the experience and knowledge of multiple healthcare executives.”

– Mike Calsin, Vice President, Sales & National Accounts

Long Grove Pharmaceuticals:
Boldly Leading With Intention

Meet the pharmaceutical industry leaders that are investing in the future—one product at a time.
Click on the biographies below to find out more.

Dan Long Grove

Dan Robins, Ph.D.

President & CEO

Leading with intention and a background rooted in robust leadership, Dan Robins, Ph.D., has more than 25 years of pharmaceutical industry experience centered in research and development. With a portfolio of growth at Mylan, Bioniche Pharma, and Abraxis BioScience, he’s also held leadership positions at Barr Laboratories, Inc. and scientific roles at Schering-Plough Research Institute Mallinckrodt Veterinary and Pentech Pharmaceuticals. With a Masters and Doctorate in chemistry from Ohio State University combined with an MBA from New York University, Dan is positioning Long Grove Pharmaceuticals to elevate the future of generics to make what’s ahead far brighter.

Read More
Pete Long Grove

Peter Karas

Chief Commercial Officer

With more than 25 years of commercial leadership experience in the pharmaceutical industry, Peter Karas has spearheaded business development, marketing, and sales for organizations across a wide variety of sectors. From Xellia Pharmaceuticals to Baxter to Fresenius Kabi, Pete has built robust product portfolios and created successful teams around the globe. Joining Long Grove in 2021, Pete is redefining the power of generic drugs—one reformulation at a time.

Read More
Dan Long Grove

Dan Robins, Ph.D.

President & CEO

Leading with intention and a background rooted in robust leadership, Dan Robins, Ph.D., has more than 25 years of pharmaceutical industry experience centered in research and development. With a portfolio of growth at Mylan, Bioniche Pharma, and Abraxis BioScience, he’s also held leadership positions at Barr Laboratories, Inc. and scientific roles at Schering-Plough Research Institute Mallinckrodt Veterinary and Pentech Pharmaceuticals. With a Masters and Doctorate in chemistry from Ohio State University combined with an MBA from New York University, Dan is positioning Long Grove Pharmaceuticals to elevate the future of generics to make what’s ahead far brighter.

Read More
Pete Long Grove

Peter Karas

Chief Commercial Officer

With more than 25 years of commercial leadership experience in the pharmaceutical industry, Peter Karas has spearheaded business development, marketing, and sales for organizations across a wide variety of sectors. From Xellia Pharmaceuticals to Baxter to Fresenius Kabi, Pete has built robust product portfolios and created successful teams around the globe. Joining Long Grove in 2021, Pete is redefining the power of generic drugs—one reformulation at a time.

Read More
Mike Long Grove

Mike Calsin

Vice President, Sales & National Accounts

From CVS Health to Fresenius Kabi, Baxter to Walgreens, and Abbott Laboratories, Mike Calsin is a seasoned pharmaceutical executive with a strong track record of igniting sales teams in large market, high-energy pharmaceutical and medical device environments. Mike has led national sales forces, created large scale marketing campaigns and facilitated multi-specialty clinical advisory boards while always working towards better understanding the voice of the customer. His ability to create sustainable energy in high-performing teams makes him a welcome addition to the team. He joins Long Grove Pharmaceuticals to manage future product pipelines, develop key customer relationships and build the most important asset–our team.

Read More
Michael Davidson Long Grove Pharmaceuticals

Mike Davidson

VP of Business Development and Licensing

Mike’s three-decade career stretches across the pharmaceutical industry, including positions with both major branded pharmaceutical companies and, for the last 15 years, on the generics side. Nearly all his generics experience has been in the areas of injectables and topical products, with a concentration since 2009 in the generics strategic business development and licensing space. Mike has successfully developed more than 30 separate strategic global partnerships covering more than 50 different products, a significant percentage of which have been successfully commercialized. 

Read More
Mike Long Grove

Mike Calsin

Vice President, Sales & National Accounts

From CVS Health to Fresenius Kabi, Baxter to Walgreens, and Abbott Laboratories, Mike Calsin is a seasoned pharmaceutical executive with a strong track record of igniting sales teams in large market, high-energy pharmaceutical and medical device environments. Mike has led national sales forces, created large scale marketing campaigns and facilitated multi-specialty clinical advisory boards while always working towards better understanding the voice of the customer. His ability to create sustainable energy in high-performing teams makes him a welcome addition to the team. He joins Long Grove Pharmaceuticals to manage future product pipelines, develop key customer relationships and build the most important asset–our team.

Read More
Michael Davidson Long Grove Pharmaceuticals

Mike Davidson

Vice President, Business Development and Licensing

Mike’s three-decade career stretches across the pharmaceutical industry, including positions with both major branded pharmaceutical companies and, for the last 15 years, on the generics side. Nearly all his generics experience has been in the areas of injectables and topical products, with a concentration since 2009 in the generics strategic business development and licensing space. Mike has successfully developed more than 30 separate strategic global partnerships covering more than 50 different products, a significant percentage of which have been successfully commercialized.

Read More
Nicole at Long Grove

Nicole Zielske

Senior Director, National Accounts

With more than 20 years of experience surpassing sales goals, Nicole Zielske shines with a passion for relationship-building and exceeding customer expectations. Nicole’s background in driving product growth at Pharmaceutical Associates, Inc., Sagent Pharmaceuticals, Premier, Inc., and AmerisourceBergen guides her approach to business management and contract negotiations, making her impactful landing at Long Grove Pharmaceuticals even more powerful.

Read More
Matt Long Grove Pharmaceuticals

Matt Henderson

Senior Director of Trade, Government & National Accounts

Matt brings over two decades of commercial and supply chain operations leadership experience to Long Grove with a solid track record of developing high performance programs and impactful customer solutions. From Xellia Pharmaceuticals to Fresenius Kabi, Hospira to Cardinal Health, Matt’s reputation for optimizing and solidifying channel strategies to deliver customer value makes him a welcome member of the Long Grove Pharmaceutical team.

Read More
Nicole at Long Grove

Nicole Zielske

Senior Director, National Accounts

With more than 20 years of experience surpassing sales goals, Nicole Zielske shines with a passion for relationship-building and exceeding customer expectations. Nicole’s background in driving product growth at Pharmaceutical Associates, Inc., Sagent Pharmaceuticals, Premier, Inc., and AmerisourceBergen guides her approach to business management and contract negotiations, making her impactful landing at Long Grove Pharmaceuticals even more powerful.

Read More
Lauren Pera Long Grove

Lauren Pera

Major Account Executive, North East Region

With over twelve years in the generic pharmaceutical industry, Lauren Pena is poised perfectly to take Long Grove to the next level. Her unique sales experience includes analgesics, critical care, oncology, anti-infectives presented in multiple delivery systems, including vials, prefilled syringes, Pre-mix bags, and IV Solutions. Consistently delivering on challenging growth targets, with an authentic enthusiasm for building customer relationships and patient care, Pera’s past partnerships include APP Pharma, which evolved into Fresenius-Kabi, USA. Lauren’s passion for sales and finding ways to help patients get the products they need is why she is a perfect fit for the Long Grove Pharmaceuticals team.

Read More
Val Hoffman Long Grove Pharmaceuticals

Valarie Hoffman, Pharm.D.

Senior Marketing Manager

Val comes to Long Grove with a diverse set of skills that spans the healthcare industry. As a PharmD and a former hospital pharmacy leader, she brings her clinical expertise and in-depth understanding of what is valuable to our healthcare customers and their patients. After a career in hospital pharmacy, Val joined Xellia Pharmaceuticals where she played integral roles to bridge clinical experts, customers, R&D and commercial teams to bring generic molecule and proprietary formulation projects to market. We welcome Val to the Long Grove team where she will have roles in managing our future product pipeline and marketing our approved products.

Read More
Matt Long Grove Pharmaceuticals

Matt Henderson

Senior Director of Trade, Government & National Accounts

Matt brings over two decades of commercial and supply chain operations leadership experience to Long Grove with a solid track record of developing high performance programs and impactful customer solutions. From Xellia Pharmaceuticals to Fresenius Kabi, Hospira to Cardinal Health, Matt’s reputation for optimizing and solidifying channel strategies to deliver customer value makes him a welcome member of the Long Grove Pharmaceutical team.

Read More
Lauren Pera Long Grove

Lauren Pera

Major Account Executive, North East Region

With over twelve years in the generic pharmaceutical industry, Lauren Pena is poised perfectly to take Long Grove to the next level. Her unique sales experience includes analgesics, critical care, oncology, anti-infectives presented in multiple delivery systems, including vials, prefilled syringes, Pre-mix bags, and IV Solutions. Consistently delivering on challenging growth targets, with an authentic enthusiasm for building customer relationships and patient care, Pera’s past partnerships include APP Pharma, which evolved into Fresenius-Kabi, USA. Lauren’s passion for sales and finding ways to help patients get the products they need is why she is a perfect fit for the Long Grove Pharmaceuticals team.

Read More
Val Hoffman Long Grove Pharmaceuticals

Valarie Hoffman

Senior Marketing Manager

Val comes to Long Grove with a diverse set of skills that spans the healthcare industry. As a PharmD and a former hospital pharmacy leader, she brings her clinical expertise and in-depth understanding of what is valuable to our healthcare customers and their patients. After a career in hospital pharmacy, Val joined Xellia Pharmaceuticals where she played integral roles to bridge clinical experts, customers, R&D and commercial teams to bring generic molecule and proprietary formulation projects to market. We welcome Val to the Long Grove team where she will have roles in managing our future product pipeline and marketing our approved products.

Read More